Thomson Pharma can help you determine the most appropriate ways to run your clinical studies, and be certain they conform to the latest regulatory standards.

No matter how far your drug has progressed along its trials,
Thomson Pharma could enhance your decision-making, speed up your processes, and get you to market faster.

• Dosage, pharmacokinetics, cautions, interactions, clinical applications, adverse effects, comparative efficacy and prescription patterns for thousands of drugs
• Data from over 2,000 of the world’s medical journals, peer-reviewed by independent experts
• Most recently reported pipeline stage for individual drugs and indications
• Predicted sales figures based on reports by analysts at major investment banks and brokerage houses
• Relevant breaking news headlines, linking to the full story

How else can it help you?

You can find the drugs that might have beneficial effects on the disease pathways of interest, and examine their documented side-effects.

You can exploit the in-depth market intelligence of Thomson Pharma to ensure your department isn’t wasting time and money on drugs that have already been patented, are already in the development pipeline of one of your competitors, or are shown not to work, and to predict the impact of new drugs.

You can identify the best processes for purification, synthesis and production and recognize the specific competitive product weaknesses that will enable you to position your product.

Thomson Pharma can help you perform the truly innovative research your organization demands, and quickly and successfully translate that research into marketable drugs.

What can you do?

With Thomson Pharma you can:

• analyze present trends in research to spot profitable new types of treatments
• view the patents your competitors are applying for
• identify and exploit gaps in the market
• review standard analytical procedures and new and emerging methodologies
• locate intermediaries, technology and licensing partners and suppliers
• report and collaborate more effectively

Where next? Competitive intelligence analysts